Kazia Therapeutics (KZIA) Shares Outstanding (2018 - 2025)

Kazia Therapeutics has reported Shares Outstanding for 8 years, with the latest figure at $518.4 million in Q2 2025.

• For the quarter ending Q2 2025, Shares Outstanding rose 136.32% year-over-year to $518.4 million; the trailing twelve-month figure through Jun 2025 stood at $518.4 million (up 136.32% YoY), and the FY2025 full-year result was $518.4 million, up 136.32% from the prior year.
• Shares Outstanding for Q2 2025 stood at $518.4 million, up from $219.4 million in the prior quarter.
• The five-year high for Shares Outstanding was $518.4 million in Q2 2025, with the low at $99.4 million in Q2 2022.
• Historically, Shares Outstanding has averaged $218.2 million across 5 years, with a median of $152.4 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding retreated 2.23% — and 2025, when it soared 136.32%.
• Kazia Therapeutics' Shares Outstanding stood at $101.7 million in 2021, then decreased by 2.23% to $99.4 million in 2022, then surged by 53.35% to $152.4 million in 2023, then soared by 43.93% to $219.4 million in 2024, then jumped by 136.32% to $518.4 million in 2025.
• The last three Shares Outstanding figures came in at $518.4 million (Q2 2025), $219.4 million (Q2 2024), and $152.4 million (Q2 2023), per Business Quant data.